Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
In experiments on male rats the pharmacokinetics of antipyrine, hexenal and phenylbutazone was studied 7 days after the liver denervation produced by subdiaphragmatic vagotomy, sympathotomy and their combination. It was found that in all variants of the liver denervation there occurs an increase of the period of half-life and a decrease of clearance of the drugs. As the liver denervation practically does not change the degree of protein binding and the hepatic blood flow velocity, it is thought that suppression of the drug biotransformation in hepatocytes due to suppression of the activity of enzymes of their microsomal oxidative system underlies changes in the pharmacokinetics of drugs.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!